BESPOKE study protocol: a multicentre, prospective observational study to evaluate the impact of circulating tumour DNA guided therapy on patients with colorectal cancer

• Scott Kopetz,
• Axel Grothey,
• Shifra Krinshpun,
• Meenakshi Malhotra,
• Paul Billings,
• Angel Rodriguez,
• Sarah Sawyer,
• Michelle Munro,
• Pashtoon Murtaza Kasi,
• Jessica Guilford,
• Sascha Ellers,
• Jacob Wulff,
• Nicole Hook,
• Allyson Koyen Malashevich,
• Solomon Moshkevich

Affiliations

Scott Kopetz

GI Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Axel Grothey

West Cancer Center and Research Institute, Germantown, Tennessee, USA

Shifra Krinshpun

Natera Inc, San Carlos, California, USA

Meenakshi Malhotra

Natera Inc, San Carlos, California, USA

Paul Billings

Natera Inc, San Carlos, California, USA

Angel Rodriguez

Natera Inc, San Carlos, California, USA

Sarah Sawyer

Natera Inc, San Carlos, California, USA

Michelle Munro

Natera Inc, San Carlos, California, USA

Pashtoon Murtaza Kasi

Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA

Jessica Guilford

Natera Inc, San Carlos, California, USA

Sascha Ellers

Natera Inc, San Carlos, California, USA

Jacob Wulff

Natera Inc, San Carlos, California, USA

Nicole Hook

Natera Inc, San Carlos, California, USA

Allyson Koyen Malashevich

Natera Inc, San Carlos, California, USA

Solomon Moshkevich

Natera Inc, San Carlos, California, USA